Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Oct 02
 +2.72 / +1.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 287.50, with a high estimate of 304.00 and a low estimate of 200.00. The median estimate represents a +57.69% increase from the last price of 182.32.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.85%
Growthannually 39.26%


Growthquarterly 1.53%
Growthannually 33.03%
Key to the earnings and sales forecast charts.